Cardiovascular Implant Company PECA Labs Names Three New Board Members
The new board members will help guide the company as it develops and commercializes cardiovascular implants based on its novel tunable polymeric material platform.
- The new board members will help guide the company as it develops and commercializes cardiovascular implants based on its novel tunable polymeric material platform.
- Dr. Carpenter is also a serial entrepreneur, including founding Embrella Cardiovascular, which was acquired by Edwards Lifesciences.
- Jeffery O’Donnell, Sr. brings to PECA Labs more than 25 years of board and chief executive experience at emerging medical device companies.
- O’Donnell founded and served as CEO for Trice Medical, and before that Embrella Cardiovascular, which was acquired by Edwards Lifesciences.